SEC Company Response from Medline (MDLN) — May 20, 2026
Medline Inc.
Date: May 20, 2026 · CIK: 0002046386 · Accession: 0001193125-26-231698
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Acceleration Request for Medline Inc. Registration Statement on Form S-1
Simpson Thacher & Bartlett LLP 900 G STREET , NW WASHINGTON , D . C . 20001
TELEPHONE : +1-202-636-5500 FACSIMILE : +1-202-636-5502
Direct Dial Number +1-202-636-5804
E-mail Address jbonnie@stblaw.com
VIA EDGAR
May 20, 2026
Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Juan Grana, Esq. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, we attach the requests of our client, Medline Inc., and of the underwriters that effectiveness of the above-referenced Registration Statement be accelerated to 4:05 p.m., Washington, D.C. time, on May 21, 2026, or as soon as practicable thereafter. Call me at (202) 636-5804 with any questions.
Very truly yours,
/s/ Joshua Ford Bonnie
Joshua Ford Bonnie NEW YORK BEIJING BOSTON BRUSSELS HONG KONG HOUSTON LONDON LOS ANGELES LUXEMBOURG PALO ALTO SAN FRANCISCO SÃO PAULO TOKYO
May 20, 2026 VIA EDGAR
Re: Medline Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Juan Grana, Esq. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Medline Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on May 21, 2026, or as soon as possible thereafter. In this regard, the Company is aware of its obligations under the Securities Act. [ Signature Page Follows ]
Very truly yours,
MEDLINE INC.
By:
/s/ Alexander M. Liberman
Name: Alexander M. Liberman
Title: Chief Legal Officer
Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282 Morgan Stanley & Co. LLC 1585 Broadway, New York, New York 10036 BofA Securities, Inc. One Bryant Park, New York, New York 10036 J.P. Morgan Securities LLC 270 Park Avenue, New York, New York 10017 May 20, 2026 VIA EDGAR
Re: Medline Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Juan Grana, Esq. Ladies and Gentlemen: In connection with the above-reference Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the proposed public offering of Medline Inc.’s (the “Company”) Class A common stock, we wish to advise you that we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on May 21, 2026 or as soon as possible thereafter or at such later time as the Company or its counsel may request. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [ Signature Page Follows ]
Very truly yours,
GOLDMAN SACHS & CO. LLC MORGAN
STANLEY & CO. LLC BOFA SECURITIES, INC.
J.P. MORGAN SECURITIES LLC
As Representatives of the Underwriters
Show Raw Text
CORRESP 1 filename1.htm CORRESP Simpson Thacher & Bartlett LLP 900 G STREET , NW WASHINGTON , D . C . 20001 TELEPHONE : +1-202-636-5500 FACSIMILE : +1-202-636-5502 Direct Dial Number +1-202-636-5804 E-mail Address jbonnie@stblaw.com VIA EDGAR May 20, 2026 Re: Acceleration Request for Medline Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Juan Grana, Esq. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, we attach the requests of our client, Medline Inc., and of the underwriters that effectiveness of the above-referenced Registration Statement be accelerated to 4:05 p.m., Washington, D.C. time, on May 21, 2026, or as soon as practicable thereafter. Call me at (202) 636-5804 with any questions. Very truly yours, /s/ Joshua Ford Bonnie Joshua Ford Bonnie NEW YORK BEIJING BOSTON BRUSSELS HONG KONG HOUSTON LONDON LOS ANGELES LUXEMBOURG PALO ALTO SAN FRANCISCO SÃO PAULO TOKYO May 20, 2026 VIA EDGAR Re: Medline Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Juan Grana, Esq. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Medline Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on May 21, 2026, or as soon as possible thereafter. In this regard, the Company is aware of its obligations under the Securities Act. [ Signature Page Follows ] Very truly yours, MEDLINE INC. By: /s/ Alexander M. Liberman Name: Alexander M. Liberman Title: Chief Legal Officer Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282 Morgan Stanley & Co. LLC 1585 Broadway, New York, New York 10036 BofA Securities, Inc. One Bryant Park, New York, New York 10036 J.P. Morgan Securities LLC 270 Park Avenue, New York, New York 10017 May 20, 2026 VIA EDGAR Re: Medline Inc. Registration Statement on Form S-1 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Juan Grana, Esq. Ladies and Gentlemen: In connection with the above-reference Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the proposed public offering of Medline Inc.’s (the “Company”) Class A common stock, we wish to advise you that we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on May 21, 2026 or as soon as possible thereafter or at such later time as the Company or its counsel may request. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [ Signature Page Follows ] Very truly yours, GOLDMAN SACHS & CO. LLC MORGAN STANLEY & CO. LLC BOFA SECURITIES, INC. J.P. MORGAN SECURITIES LLC As Representatives of the Underwriters By: GOLDMAN SACHS & CO. LLC By: /s/ Lyla Bibi Maduri Name: Lyla Bibi Maduri Title: Managing Director By: MORGAN STANLEY & CO. LLC By: /s/ Kalli Dircks Name: Kalli Dircks Title: Managing Director By: BOFA SECURITIES, INC. By: /s/ Justin Walter Name: Justin Walter Title: Managing Director By: J.P. MORGAN SECURITIES LLC By: /s/ Benjamin Burdett Name: Benjamin Burdett Title: Head of Healthcare ECM